Develops drugs for autoimmune diseases.
Jun 2026Revenue $64.4B/yrExpenses $47.5B/yr
No trend
Figures by year
Is AbbVie profitable?
Yes. In the 12 months to Jun 2026, revenue was $64.4B and expenses $47.5B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $61.2B | $46.1B | $15.1B |
| Dec 2024 | $56.3B | $47.2B | $9.14B |
| Dec 2023 | $54.3B | $41.6B | $12.8B |
| Dec 2022 | $58.1B | $39.9B | $18.1B |
| Dec 2021 | $56.2B | $38.3B | $17.9B |
| Dec 2020 | $45.8B | $34.4B | $11.4B |
| Dec 2019 | $33.3B | $20.3B | $13.0B |
| Dec 2018 | $32.8B | $26.4B | $6.38B |
| Dec 2017 | $28.2B | $18.7B | $9.54B |
| Dec 2016 | $25.6B | $16.3B | $9.34B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.